Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: what do we know and future vistas
Roger S. McIntyre
Abstract
1. Within the last year, the European Medicines Agency (EMA), Food and Drug Administration (FDA) and the Medicines and Healthcare Products Regulatory Agency in the United Kingdom (MHRA) began inves...
Topics & Concepts
Glucagon-like peptide-1Glucagon-like peptide 1 receptorMedicineReceptorGlucagonPeptideAgonistEndocrinologyPharmacologyInternal medicineBiochemistryInsulinChemistryDiabetes mellitusType 2 diabetesDiabetes Treatment and ManagementDiabetes Management and ResearchElectrolyte and hormonal disorders